SEC Tracker
Get the app

Bionano Genomics BNGO

Bionano reported Q3 2026 results

Bionano Genomics (BNGO) filed an 8-K with the SEC on Nov 10, 2026, 4:03 pm ET. Source: the filing on SEC EDGAR.

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Revenue of $8.3 million, up 12% from $7.4 million in Q3 2025
  2. Consumables revenue increased 24% to $4.7 million
  3. Sold 9,870 flowcells, up 18% from 8,390 in Q3 2025
  4. Gross margin improved to 48% from 46%

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Bionano Genomics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.